Cure My Disease

Don't miss your cure!

 Log in / Sign up

New contact lens study sees clearly for presbyopia patients

NCT ID NCT06469242

Symptom relief Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different multifocal contact lenses in 106 people with presbyopia, an age-related condition that makes it hard to see up close. Participants wore each lens for a week to see how well they could see at different distances. The goal was to compare the performance of the two lenses for everyday use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

106 people

The number who actually took part.

Started

Jul 2024

Finished

Oct 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Current wearer of biweekly/monthly replacement multifocal soft contact lenses in both eyes for a minimum of 5 days per week and 10 hours per day during the past 6 months. * Manifest cylinder equal to or less than 0.75 diopter (D) in each eye. * Able to wear contact lenses within the available power range with a near ADD of +0.75 D to +2.50 D in each eye. * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Currently pregnant or lactating. * History of amblyopia, strabismus, or binocular vision abnormalities. * Habitual Oasys MF contact lens wearers or daily disposable contact lens wearers. * Monovision contact lens wearers and wearers of contact lens in one eye only. * Other protocol-defined exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Presbyopia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperopia myopia presbyopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Presbyopia

Contacts and locations

Locations

  • Drs. Giedd, P.A.

    Maitland, Florida, 32751, United States

  • Elsa Pao, OD

    Oakland, California, 94607, United States

  • Insight Research Clinic LLC

    Powell, Ohio, 43065, United States

  • Kurata Eyecare Center

    Los Angeles, California, 90013, United States

  • Optometry Group, PLLC

    Memphis, Tennessee, 38111, United States

  • ProCare Vision Centers, Inc.

    Granville, Ohio, 43023, United States

  • Vision Health Institute

    Orlando, Florida, 32803, United States

  • Wesley Optometric Consulting

    Medina, Minnesota, 55340, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.